Sunday, March 16, 2008

Fwd: Asbestos worry over teacher death



---------- Forwarded message ----------
From: Live Search News: asbestos cancer <rssfwd@rssfwd.com>
Date: Sun, Mar 16, 2008 at 1:56 AM
Subject: Asbestos worry over teacher death
To: mesothelioma77@gmail.com


BBC UK News - The widower of a retired art teacher who died of asbestos-related lung cancer says it is suspected she was exposed to asbestos at school. A coroner is writing to Flintshire Council over possible dangers after the death of Renee Blodwen Eden, 69, who ...

Fri, 14 Mar 2008 15:42:00 GMT

___
Source: http://news.bbc.co.uk/2/hi/uk_news/wales/north_east/7296471.stm
--
 Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc

 ================
 
 
 
 

Fwd: Malignant pleural mesothelioma: utility of 18 F-FDG PET.



---------- Forwarded message ----------
From: HubMed - mesothelioma cancer <rssfwd@rssfwd.com>
Date: Sun, Mar 16, 2008 at 1:55 AM
Subject: Malignant pleural mesothelioma: utility of 18 F-FDG PET.
To: mesothelioma77@gmail.com


[1]Ann Ital Chir. 2007 Sep-Oct; 78(5): 393-6
Spitilli MG, Treglia G, Calcagni ML, Giordano A

Malignant Pleural Mesothelioma is a rare tumour that arise from the mesothelial cells of the pleura and in recent time the incidence of this disease is rising. Because of the implications for management and therapy, it is important to assess the accurate staging. 18F-fluorodeoxiglucose Positron Emission Tomography (18F-FDG PET) is become a useful tool in the diagnosis of many neoplasms, such as Malignant Pleural Mesothelioma. In particular it has been shown to be useful in the evaluation of the extent of pleural disease, in the establishment of lymph node involvement, in the evaluation of tumour invasion into the lung and thoracic wall, in the diagnosis of extrathoracic metastases, in the assessment of the response to treatment, and in planning radiotherapy. Developments in system technology, like improvements in hybrid system (integrated Positron Emission Tomography/Computed Tomography) and the discovery of new radiopharmaceuticals, promise to make PET much more useful and versatile in the future.



___
Source: http://www.hubmed.org/display.cgi?uids=18338546
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: [Malignant pleural effusion]



---------- Forwarded message ----------
From: HubMed - mesothelioma cancer <rssfwd@rssfwd.com>
Date: Sun, Mar 16, 2008 at 1:55 AM
Subject: [Malignant pleural effusion]
To: mesothelioma77@gmail.com


[1]Ann Ital Chir. 2007 Sep-Oct; 78(5): 389-91
Cusumano G, Margaritora S, Porziella V, Meacci E, Piraino A, Vita ML, Tessitore A, Congedo MT, Filotico M, Cafarotti S, Granone P

Malignant pleural effusion is a frequent condition with important prognostic repercussions on duration and quality of life. The neoplasms that more frequently determine pleural effusion are lung and breast cancer and pleural mesothelioma. Lymphomas, tumours of the genitourinary tract and gastrointestinal tract as a group account for a further 25%. Surgical treatment has palliative purposes and finalized to reduction symptoms and to improve quality of life. More frequent clinical presentation is a massive pleural efusion associated to dyspnoea and cough. Pleural aspiration is the first choice treatment but the recurrence rate equals to 100% within 1 month. Repeated pleural aspirations are indicated in those patients that have lower expectation of life. The recurrence risk can be reduced with chemical pleurodesis that allows the adhesion between pleural surfaces. Pleurodesis can be realized by the instillation of several substances by the tube of drainage (slurry) or during thoracoscopy (poudrage). Video Assisted Thoracoscopy (VATS) is a safe and well tolerated technique, a complication rate is lower than 0.5%, VATS can be used to obtain diagnosis and to treat patients with malignant pleural effusion and better expectation of life.



___
Source: http://www.hubmed.org/display.cgi?uids=18338545
--
 ~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 ==========
 
 
 

Mesothelioma Diagnosis and What You Need To Know

Mesothelioma Diagnosis and What You Need To Know
Unlike lung cancer, there is no association between mesothelioma and smoking Transcendently people who develop mesothelioma have on worked on jobs where they inhaled asbestos particles, or require been exposed to asbestos dust and fibre in other ways, such as by washing the clothes of a family member who worked with asbestos, or by home renovation using asbestos cement products. Mesothelioma is the word used to describe a cancerous tumor that involves the mesothelial cells of an organ, often the lungs, heart, or abdominal organs. Malignancies involving mesothelial cells in these measurement cavities are known as malignant mesothelioma, which may be localized or diffuse.
 
Its top-notch defined site is the pleura (outer lining of the lungs and chest cavity), but it may also occur in the peritoneum (the lining of the abdominal cavity) or the pericardium (a sac that surrounds the heart).
 Malignant mesothelioma has a peak incidence 35-45 years after asbestos exposure.
 
Other symptoms of peritoneal mesothelioma may include bowel obstruction, blood clotting abnormalities, anemia, and fever. Mesothelioma is diagnosed by pathological examination from a biopsy. Diagnosing mesothelioma is often difficult, because the symptoms are similar to those of a number of other conditions. Symptoms of mesothelioma may not appear until 20 to 50 years after exposure to asbestos. Diagnosis begins with a review of the patient's medical history.
 
If the cancer has length beyond the mesothelium to other parts of the spread, symptoms may include pain, trouble swallowing, or swelling of the neck or relate to.
  A history of exposure to asbestos may increase clinical suspicion for mesothelioma.  A physical examination is performed, followed by chest X-ray and often lung function tests.
 
The X-ray may reveal pleural thickening commonly seen after asbestos exposure and increases suspicion of mesothelioma. Malignant mesothelioma is a rare type of cancer in which malignant cells are found in the sac lining the chest or abdomen. Malignant mesothelioma is more undistorted in men, with a male-to-female ratio of 3:1. 
 
It can also occur in children; however, these cases are not thought to be associated with asbestos exposure.
 Malignant mesothelioma has also been linked to curing radiation using thorium dioxide and zeolite, a silicate in the soil.
 Perfectly people with malignant mesothelioma have worked on jobs where they breathed asbestos. Most malignant mesotheliomas let complex karyotypes, with extensive aneuploidy and rearrangement of many chromosomes. Malignant mesothelioma is often just called simply Mesothelioma and is a mastery of lung cancer that is quite rare.
 
Exposure to airborne asbestos particles increases one's risk of developing malignant mesothelioma.
 Mesothelial cells normally line the spread cavities, including the pleura, peritoneum, pericardium, and testis.
 
There are now a number of cancer treatment options approachable to mesothelioma patients. Extrapleural pneumonectomy for selected patients with very early stage disease may make a success recurrence-free survival, but the impact it has on overall survival is unknownat this time. Extrapleural pneumonectomy is a more extensive procedure and has a higher mortality rate. Recently, the mortality rate has been lowered to 3.8%. It involves dissection of the parietal pleura; division of the pulmonary vessels; and en bloc resection of the lung, pleura, pericardium, and diaphragm followed by reconstruction. It provides the transcendently local control because it removes the all-out pleural sac along with the lung parenchyma.
 Surgical resection has been relied upon because radiation and chemotherapy have on been ineffective absolute treatments.
 
The desire of radiation restorative in pleural mesothelioma has been shown to relieve suffering in the majority of patients that are treated. But unfortunately, the duration of symptom control is short-lived. Radiation has no effect on survival, but it has caused significant palliation in 50% of patients treated for chest pain and chest wall metastasis.


Never miss a thing. Make Yahoo your homepage.